纳武单抗联合伊匹单抗致贝克囊肿破裂1例

IF 1.1 Q4 ALLERGY

Journal of Cutaneous Immunology and Allergy Pub Date : 2023-03-09 DOI:10.1002/cia2.12290

Marie Kubo MD, Tomomitsu Miyagaki MD, PhD, Hiroyuki Ohashi MD, Arisa Kishi MD, Kaoru Miyano MD, Tatsuro Okano MD, PhD, Mayuko Muto MD, Sora Takeuchi MD, PhD, Mitsuru Imamura MD, PhD, Takafumi Kadono MD, PhD

{"title":"纳武单抗联合伊匹单抗致贝克囊肿破裂1例","authors":"Marie Kubo MD, Tomomitsu Miyagaki MD, PhD, Hiroyuki Ohashi MD, Arisa Kishi MD, Kaoru Miyano MD, Tatsuro Okano MD, PhD, Mayuko Muto MD, Sora Takeuchi MD, PhD, Mitsuru Imamura MD, PhD, Takafumi Kadono MD, PhD","doi":"10.1002/cia2.12290","DOIUrl":null,"url":null,"abstract":"<p>Here, we presented the rare case of ruptured Baker's cyst induced by immune checkpoint inhibitors (ICIs). The history of more than one immune-related adverse event (irAE) like our case was reported to be associated with a more persistent course of arthritis. Mild persistent inflammation without subjective symptoms might exist after first ICI therapy followed by ruptured Baker's cyst. It is important to pay attention to potential musculoskeletal irAEs in ICI-treated patients with multiple irAEs.\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure></p>","PeriodicalId":15543,"journal":{"name":"Journal of Cutaneous Immunology and Allergy","volume":null,"pages":null},"PeriodicalIF":1.1000,"publicationDate":"2023-03-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12290","citationCount":"0","resultStr":"{\"title\":\"A case of ruptured Baker's cyst induced by nivolumab and ipilimumab\",\"authors\":\"Marie Kubo MD, Tomomitsu Miyagaki MD, PhD, Hiroyuki Ohashi MD, Arisa Kishi MD, Kaoru Miyano MD, Tatsuro Okano MD, PhD, Mayuko Muto MD, Sora Takeuchi MD, PhD, Mitsuru Imamura MD, PhD, Takafumi Kadono MD, PhD\",\"doi\":\"10.1002/cia2.12290\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>Here, we presented the rare case of ruptured Baker's cyst induced by immune checkpoint inhibitors (ICIs). The history of more than one immune-related adverse event (irAE) like our case was reported to be associated with a more persistent course of arthritis. Mild persistent inflammation without subjective symptoms might exist after first ICI therapy followed by ruptured Baker's cyst. It is important to pay attention to potential musculoskeletal irAEs in ICI-treated patients with multiple irAEs.\\n <figure>\\n <div><picture>\\n <source></source></picture><p></p>\\n </div>\\n </figure></p>\",\"PeriodicalId\":15543,\"journal\":{\"name\":\"Journal of Cutaneous Immunology and Allergy\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.1000,\"publicationDate\":\"2023-03-09\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://onlinelibrary.wiley.com/doi/epdf/10.1002/cia2.12290\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of Cutaneous Immunology and Allergy\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/cia2.12290\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ALLERGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Cutaneous Immunology and Allergy","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/cia2.12290","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ALLERGY","Score":null,"Total":0}

引用次数: 0

摘要

新出现的证据表明，免疫检查点抑制剂（ICIs）通过增强抗肿瘤免疫反应，对各种恶性肿瘤具有巨大疗效。相反，ICIs可引起免疫相关不良反应（irAE），影响各种器官系统。在这里，我们报告了罕见的由ICIs引起的贝克囊肿破裂的病例。一位50岁的日本妇女转诊到我科，有3个月外阴肿大结节病史。她没有肌肉骨骼疾病史。临床检查显示，右侧外阴有一个12×16毫米大小的黑色结节（图1A），同侧腹股沟淋巴结肿大。肿瘤被切除，边缘为10mm，并进行前哨淋巴结活检（SLNB）。切除标本显示真皮中有大量圆形至椭圆形的黑色素肿瘤细胞浸润（图1B）。肿瘤厚度为2.9mm，SLNB为阴性。发现正电子发射断层扫描计算机断层扫描（CT）

本文章由计算机程序翻译，如有差异，请以英文原文为准。

A case of ruptured Baker's cyst induced by nivolumab and ipilimumab

查看原文本刊更多论文

A case of ruptured Baker's cyst induced by nivolumab and ipilimumab

Here, we presented the rare case of ruptured Baker's cyst induced by immune checkpoint inhibitors (ICIs). The history of more than one immune-related adverse event (irAE) like our case was reported to be associated with a more persistent course of arthritis. Mild persistent inflammation without subjective symptoms might exist after first ICI therapy followed by ruptured Baker's cyst. It is important to pay attention to potential musculoskeletal irAEs in ICI-treated patients with multiple irAEs.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Journal of Cutaneous Immunology and Allergy Medicine-Dermatology

CiteScore

0.60

自引率

10.00%

发文量

审稿时长

12 weeks